Genetic relatedness and host specificity of Pseudomonas aeruginosa isolates from cystic fibrosis and non-cystic fibrosis patients

被引:5
|
作者
AbdulWahab, Atqah [1 ]
Taj-Aldeen, Saad J. [2 ]
Ibrahim, Emad [2 ]
Abdulla, Shaikha H. [3 ]
Muhammed, Ramees [3 ]
Ahmed, Irshad [3 ]
Abdeen, Yasmine [4 ]
Sadek, Omnia [4 ]
Abu-Madi, Marawan [4 ]
机构
[1] Hamad Med Corp, Dept Pediat, POB 3050, Doha, Qatar
[2] Hamad Med Corp, Dept Lab Med & Pathol, Microbiol Div, Doha, Qatar
[3] Qatar Univ, Supreme Council Hlth, Cent Food Labs, Mol Biol Unit, Doha, Qatar
[4] Qatar Univ, Coll Arts & Sci, Dept Hlth Sci, Doha, Qatar
来源
关键词
cystic fibrosis; drug susceptibility testing; Pseudomonas aeruginosa; pulsed-field gel electrophoresis;
D O I
10.2147/IDR.S72112
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Pseudomonas aeruginosa is one of the primary pathogens isolated more frequently in cystic fibrosis (CF) and it exhibits innate resistance to a wide range of antibiotics. Purpose: We sought to determine whether the highly prevalent genotypes of P. aeruginosa are specifically linked to CF patients and have any related multidrug antibiotic resistance. Isolates from hospitalized non-CF patients and from environmental sources were also genotypically analyzed. Methods: Collections of P. aeruginosa from lower respiratory secretions (n=45) were genotyped using pulsed-field gel electrophoresis (PFGE). Phenotypic screening for antibiotic susceptibility was performed for the common antimicrobial agents by E-test and automated Phoenix method. Results: P. aeruginosa isolates from CF (n=32), hospitalized non-CF patients (n=13), and environment sources (n=5) were analyzed. The population structure of P. aeruginosa is highly diverse and population-specific. All PFGE results of P. aeruginosa isolates fall among four major clusters. Cluster 1 contained 16 P. aeruginosa isolates from CF patients and two from environmental sources; cluster 2 contained 11 P. aeruginosa isolates from CF and one each from non-CF and environmental sources; cluster 3 contained 12 P. aeruginosa isolates from hospitalized non-CF patients and two P. aeruginosa isolates from one CF patient and one environmental source; and cluster 4 consisted of three isolates from CF patients and one from the environment. The majority of multidrug-resistant P. aeruginosa isolates were in clusters 3 and 4. P. aeruginosa isolates from CF patients were resistant to ciprofloxacin (34.4%) followed by resistance to amikacin and gentamicin (each 28%), whereas the majority of isolates from non-CF patients were resistant to meropenem (69%) and were grouped in cluster 3. Conclusion: PFGE of P. aeruginosa isolates from CF patients shows a high degree of similarity, suggesting specific adaptation of these clones to CF-affected lungs. The hospitalized non-CF cluster has a different clonal origin, indicating specific clustering in a specific location, suggesting hospital-acquired P. aeruginosa infections.
引用
下载
收藏
页码:309 / 316
页数:8
相关论文
共 50 条
  • [21] Susceptibility of Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients to Ciprofloxacin
    A. Bauernfeind
    R. Jungwirth
    F. Ratjen
    Drugs, 1999, 58 : 209 - 210
  • [22] Simultaneous overexpression of multidrug efflux pumps in Pseudomonas aeruginosa non-cystic fibrosis clinical isolates
    Poonsuk, Kanchana
    Tribuddharat, Chanwit
    Chuanchuen, Rungtip
    CANADIAN JOURNAL OF MICROBIOLOGY, 2014, 60 (07) : 437 - 443
  • [23] Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung
    Hilliam, Yasmin
    Moore, Matthew P.
    Lamont, Iain L.
    Bilton, Diana
    Haworth, Charles S.
    Foweraker, Juliet
    Walshaw, Martin J.
    Williams, David
    Fothergill, Joanne L.
    De Soyza, Anthony
    Winstanley, Craig
    EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (04)
  • [24] Eradication Therapy against Pseudomonas aeruginosa in Non-Cystic Fibrosis Bronchiectasis
    Orriols, Ramon
    Hernando, Rosana
    Ferrer, Adelaida
    Terradas, Sonia
    Montoro, Bruno
    RESPIRATION, 2015, 90 (04) : 299 - 305
  • [25] Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients
    Anthony, M
    Rose, B
    Pegler, MB
    Elkins, M
    Service, H
    Thamotharampillai, K
    Watson, J
    Robinson, M
    Bye, P
    Merlino, J
    Harbour, C
    JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (08) : 2772 - 2778
  • [26] Mucoid Pseudomonas aeruginosa alters sputum viscoelasticity in patients with non-cystic fibrosis bronchiectasis
    Alcaraz-Serrano, Victoria
    Fernandez-Barat, Laia
    Scioscia, Giulia
    Llorens-Llacuna, Joan
    Gimeno-Santos, Elena
    Herrero-Cortina, Beatriz
    Vazquez, Nil
    Puig de la Bellacasa, Jordi
    Gabarrus, Albert
    Amaro-Rodriguez, Rosanel
    Menendez, Rosario
    Torres, Antoni
    RESPIRATORY MEDICINE, 2019, 154 : 40 - 46
  • [27] Efficacy of nebulised colomycin in patients with non-cystic fibrosis bronchiectasis colonised with Pseudomonas aeruginosa
    Dhar, R.
    Anwar, G. A.
    Bourke, S. C.
    Doherty, L.
    Middleton, P.
    Ward, C.
    Rutherford, R. M.
    THORAX, 2010, 65 (06) : 553 - 553
  • [28] Experience with nebulised colistin in patients with non-cystic fibrosis bronchiectasis colonised with Pseudomonas aeruginosa
    Lopez-Gil Otero, Maria del Mar
    Yaiza Romero-Ventosa, Elena
    Feijoo-Melendez, Debora
    Casanova-Martinez, Cristina
    Otero-Millan, Luis
    Pineiro-Corrales, Guadalupe
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2019, 32 (03) : 217 - 223
  • [29] Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis Preface
    Jones, Andrew M.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 36 (02) : 167 - 167
  • [30] Serratiopeptidase Affects the Physiology of Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
    Artini, Marco
    Vrenna, Gianluca
    Trecca, Marika
    Assanti, Vanessa Tuccio Guarna
    Fiscarelli, Ersilia Vita
    Papa, Rosanna
    Selan, Laura
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)